ALHC Stock Recent News
ALHC LATEST HEADLINES
Although the revenue and EPS for Alignment Healthcare (ALHC) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
The specialty insurer is partnering with a top pharmacy chain operator for new policies. These will be available in a selection of markets, potentially covering 1.6 mllion eligible people.
Alignment Healthcare (ALHC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
ORANGE, Calif., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), will release its third quarter 2023 financial results on Thursday, Nov. 2, after market close. Following the release, the company will host a conference call to review its financial results at 5:30 p.m. EDT.
Alignment Healthcare (ALHC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
ORANGE, Calif., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), a tech-enabled Medicare Advantage company, today announced that John Kao, founder and CEO, and Thomas Freeman, chief financial officer, will participate in the Morgan Stanley 21st Annual Global Healthcare Conference, being held in New York, New York, including a presentation on Wednesday, Sept. 13, at 1:35 p.m. EDT.
Alignment Healthcare, Inc. (NASDAQ:ALHC ) Q2 2023 Earnings Conference Call August 3, 2023 5:30 PM ET Company Participants John Kao - CEO Thomas Freeman - CFO Conference Call Participants Ryan Daniels - William Blair Michael Ha - Morgan Stanley Whit Mayo - SVB Adam Ron - Bank of America Gary Taylor - Cowen Jessica Tassan - Piper Sandler Calvin Sternick - JPMorgan Nathan Rich - Goldman Sachs Operator Good afternoon and welcome to the Alignment Healthcare Second Quarter 2023 Earnings Conference Call and Webcast. All participants will be in a listen-only mode.
While the top- and bottom-line numbers for Alignment Healthcare (ALHC) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Alignment Healthcare (ALHC) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to loss of $0.06 per share a year ago.
The market has already risen sharply this year, but Wall Street analysts think these two stocks haven't received the attention they deserve. Caribou Biosciences is a clinical-stage drugmaker developing one-size-fits-all cellular cancer therapies.